Galeterone and alternative splicing does this agent differ from approved agents such as abiraterone and enzalutamide - 101950

Spotlight
Video

Galeterone and alternative splicing does this agent differ from approved agents such as abiraterone and enzalutamide

Loading........
Description: Dr. David Michael Nanus, M.D. of Weill Cornell Medicine discusses galeterone and alternative splicing does this agent differ from approved agents such as abiraterone and enzalutamide at ASCO GU 2016 in San francisco.
Shared By : Genitourinary-Cancer-Meeting
Posted on : 01/12/16
Added : 3 years ago
Category : Prostate Cancer